Bluepharma will open a new production unit in Coimbra for complex injectable medicines related to gene therapy, with operations expected to start in April; the project is the result of a consortium of ten entities and marks further investment in pharmaceutical innovation. The unit is intended to support manufacturing capacity for advanced therapies and may create specialised local jobs. Healthcare and biotech workers, and regional suppliers, should watch hiring and procurement notices as the unit becomes operational.